Novel Treatments for Neuromuscular Disorders

 

Flex Pharma, Inc. is a clinical-stage biotechnology company founded by National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of ion channels and neurobiology, along with Christoph Westphal, M.D., Ph.D. 

Spotlight

March 6, 2019 Flex Pharma Reports Fourth Quarter and Fiscal 2018 Financial Results
Read More

January 4, 2019 Flex Pharma and Salarius Pharmaceuticals Announce Merger Agreement to Accelerate Clinical Development of Novel Epigenetic Therapy for Cancer
Read More